as on January 28, 2026 at 9:24 pm IST
Day's High
3.33%
Upside
52 Week's Low
52 Week's High
10.00%
Downside
545.00%
Upside
Check Nexalin Technology Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$11.2M
EPS (TTM)
-0.49
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-178.46%
Compare market cap, revenue, PE, and other key metrics of Nexalin Technology Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $11.2M | NA | NA | 0.00% | |
| BUY | $138.7B | 157.59% | 50.03 | 14.43% | |
| BUY | $136.5B | 54.16% | 46.97 | 12.07% | |
| BUY | $129.1B | -12.27% | 27.28 | 13.71% | |
| BUY | $49.1B | 0.26% | 36.83 | 23.25% |
The Nexalin Technology Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Nexalin Technology Inc investment value today
Current value as on today
₹29,321
Returns
Returns from Nexalin Technology Inc Stock
Dollar Returns*
₹5,974 (+5.97%)
Search interest for Nexalin Technology Inc Stock has increased by 29% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:29% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 3 years, Boston Scientific Corp. has given 7.0% return, outperforming this stock by 54.1%
Against Peers
![]()
In the last 1 year, Edwards Lifesciences Corp. has given 15.2% return, outperforming this stock by 92.2%
Profit Down
![]()
Netprofit is down for the last 2 quarters, -1.58M → -2.27M (in $), with an average decrease of 44.0% per quarter
Price Dip
![]()
In the last 3 months, NXL stock has moved down by -60.0%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 70.58K → 18.14K (in $), with an average decrease of 74.3% per quarter
| Organisation | Nexalin Technology Inc |
| Headquarters | 1776 Yorktown, Houston, TX, United States, 77056 |
| CEO | Mr. Mark White |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Mark White | President, CEO & Director |
Dr. David Owens M.D. | Chief Medical Officer, Member of Scientific Advisory Board & Director |
Ms. Carolyn Shelton | Executive VP of Clinical, Quality & Regulatory Affairs |
Mr. John Patrick Claude | Co-Founder and Director of Engineering & Development |
Mr. Justin Van Fleet CPA | Chief Financial Officer |
Nexalin Technology Inc share price today is $0.6 as on . Nexalin Technology Inc share today touched a day high of $0.62 and a low of $0.6.
Nexalin Technology Inc share touched a 52 week high of $3.87 on and a 52 week low of $0.54 on . Nexalin Technology Inc stock price today i.e. is trending at $0.6,which is 84.50% down from its 52 week high and 11.11% up from its 52 week low.
Nexalin Technology Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Nexalin Technology Inc (NXL) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Nexalin Technology Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Nexalin Technology Inc share’s latest price of $0.6 as on January 28, 2026 at 9:24 pm IST, you will get 16.6667 shares of Nexalin Technology Inc. Learn more about
fractional shares .